Akero Therapeutics Inc (AKRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 35,629 | 28,753 | 25,420 | 36,091 | 27,594 |
| Operating Income | -35,629 | -28,753 | -25,420 | -36,091 | -27,594 |
| Interest Expense | 857 | 0 | 0 | 0 | 0 |
| Other Income | 5,403 | 2,922 | 2,361 | 549 | 191 |
| Pre-tax Income | -31,083 | -25,831 | -23,059 | -35,542 | -27,403 |
| Net Income Continuous | -31,083 | -25,831 | -23,059 | -35,542 | -27,403 |
| Net Income | $-31,083 | $-25,831 | $-23,059 | $-35,542 | $-27,403 |
| EPS Basic Total Ops | -0.60 | -0.55 | -0.44 | -0.92 | -0.77 |
| EPS Basic Continuous Ops | -0.60 | -0.55 | -0.44 | -0.92 | -0.77 |
| EPS Diluted Total Ops | -0.60 | -0.55 | -0.44 | -0.92 | -0.77 |
| EPS Diluted Continuous Ops | -0.60 | -0.55 | -0.44 | -0.92 | -0.77 |
| EPS Diluted Before Non-Recurring Items | -0.60 | -0.55 | -0.49 | N/A | N/A |
| EBITDA(a) | $-36,877 | $-29,910 | $-25,510 | $-35,985 | $-27,521 |